Akebia Therapeutics
AKBA
#7709
Rank
โ‚น33.07 B
Marketcap
โ‚น124.66
Share price
-1.43%
Change (1 day)
-23.07%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: โ‚น33.07 Billion

As of January 2026 Akebia Therapeutics has a market cap of โ‚น33.07 Billion. This makes Akebia Therapeutics the world's 7709th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น33.07 B-16.35%
2025โ‚น39.54 B8.35%
2024โ‚น36.49 B87.68%
2023โ‚น19.44 B121.4%
2022โ‚น8.78 B-70.16%
2021โ‚น29.43 B-0.56%
2020โ‚น29.59 B-46.03%
2019โ‚น54.83 B21.33%
2018โ‚น45.19 B0.71%
2017โ‚น44.88 B65.54%
2016โ‚น27.11 B2.98%
2015โ‚น26.32 B75.19%
2014โ‚น15.02 B

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of Akebia Therapeutics was reported to be:

โ‚น33.07 Billion
by Nasdaq info icon info icon
โ‚น33.07 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
โ‚น15.774 T 47,586.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น24.544 T 74,098.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Johnson & Johnson
JNJ
โ‚น46.497 T 140,462.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚น67.21 B 103.19%๐Ÿ‡บ๐Ÿ‡ธ USA